The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00293.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Lisa Reisbeck und 10 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurosurgery, Department of Neurosurgery, Neuroscience Center, Goethe University Hospital, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Deutsche Krebshilfe.
Abstract (Originalsprache)
Induction of cell-lethal autophagy represents a possible strategy to combat glioblastoma (GBM). Here, we demonstrate that the novel iron chelator and OXPHOS inhibitor VLX600 exerts pronounced tumor cell-killing effects in adherently cultured GBM cells and glioblastoma stem-like cell (GSC) spheroid cultures that depend on the iron-chelating function of VLX600 and on autophagy activation, underscoring the context-dependent role of autophagy in therapy responses. VLX600 represents an interesting novel drug candidate for the treatment of this tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Neurosurgery, Department of Neurosurgery, Neuroscience Center, Goethe University Hospital, Frankfurt am Main, Germany.
- Institute of Biochemistry II, Goethe University, Frankfurt am Main, Germany.
- Neurological Institute (Edinger Institute), Goethe University Hospital, Frankfurt am Main, Germany.
- Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
- University Cancer Center Frankfurt (UCT), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
- German Cancer Consortium (DKTK), Partner site Frankfurt/Main, a partnership between DKFZ and University Hospital, Frankfurt, Germany.
ORCID-Profile: Rolf Marschalek, Liliana Schaefer, Donat Kögel
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Deutsche Krebshilfe
Zitieren
APA
Reisbeck, L., Linder, B., Tascher, G., Bozkurt, S., Weber, K. J., Herold-Mende, C., van Wijk, S. J. L., Marschalek, R., Schaefer, L., Münch, C., & Kögel, D. (2023). The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00293.2023
Vancouver
Reisbeck L, Linder B, Tascher G, Bozkurt S, Weber KJ, Herold-Mende C, et al. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00293.2023
BibTeX
@article{Reisbeck2023,
author = {Reisbeck, Lisa and Linder, Benedikt and Tascher, Georg and Bozkurt, Süleyman and Weber, Katharina J and Herold-Mende, Christel and van Wijk, Sjoerd J L and Marschalek, Rolf and Schaefer, Liliana and Münch, Christian and Kögel, Donat},
title = {The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00293.2023}
}
EUVIMED